참고문헌
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated) [Internet]. GOLD, 2013 [cited 2015 Jul 28]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
- The Korean Academy of Tuberculosis and Respiratory Diseases. Guidelines for chronic obstructive pulmonary disease 2012 [Internet]. Seoul (KR): KATRD, c2007 [cited 2015 Jul 28]. Available from: http://www.lungkorea.org.
- Zhou QT, Mei JJ, He B, et al. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chin Med J (Engl) 2013;126:11-15.
- Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50. https://doi.org/10.1016/S2213-2600(12)70044-9
- Kirkpatrick d P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009;15:100-104. https://doi.org/10.1097/MCP.0b013e3283232825
- Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006;27:463-471. https://doi.org/10.1016/j.ccm.2006.04.005
- Barnes PJ. Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999;54:245-252. https://doi.org/10.1136/thx.54.3.245
- Hegab AE, Sakamoto T, Uchida Y, et al. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J Med Genet 2004;41:e27. https://doi.org/10.1136/jmg.2003.012484
- Ho LI, Harn HJ, Chen CJ, Tsai NM. Polymorphism of the beta(2)-adrenoceptor in COPD in Chinese subjects. Chest 2001;120:1493-1499. https://doi.org/10.1378/chest.120.5.1493
- Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-338. https://doi.org/10.1164/rccm.200712-1869OC
- Hansel NN, Washko GR, Foreman MG, et al. Racial differences in CT phenotypes in COPD. COPD 2013;10:20-27. https://doi.org/10.3109/15412555.2012.727921
- Kwon N, Amin M, Hui DS, et al. Validity of the COPD assessment test translated into local languages for Asian patients. Chest 2013;143:703-710. https://doi.org/10.1378/chest.12-0535
- Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont: Wadsworth International Group, 1984.
- Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996;335:1198-1205. https://doi.org/10.1056/NEJM199610173351606
- Small M, Broomfield S, Higgins V. Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy. Thorax 2012;67:A144-A145.
- Adamek L, Jones P, Nadeau G, Banik N. GOLD 2011: combined COPD assessment of patients from the European health-related quality of life study. Eur Respir J 2012;40(Suppl 56):1644.
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012. https://doi.org/10.1056/NEJMoa021322
- Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374:704-711. https://doi.org/10.1016/S0140-6736(09)61301-5
- Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT) scores. BMC Pulm Med 2011;11:42. https://doi.org/10.1186/1471-2466-11-42
- Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172-181. https://doi.org/10.1207/S15324796ABM2603_02
- Decramer M, Miravitlles M, Price D, et al. New horizons in early stage COPD: improving knowledge, detection and treatment. Respir Med 2011;105:1576-1587. https://doi.org/10.1016/j.rmed.2010.12.015
- Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994;272:1497-1505. https://doi.org/10.1001/jama.1994.03520190043033
- Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178. https://doi.org/10.1016/S0140-6736(09)61298-8
피인용 문헌
- COPD assessment test score and serum C-reactive protein levels in stable COPD patients vol.11, pp.None, 2015, https://doi.org/10.2147/copd.s118153
- Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation vol.13, pp.None, 2015, https://doi.org/10.2147/copd.s149805
- The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients vol.18, pp.None, 2015, https://doi.org/10.1186/s12890-018-0601-0
- Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease : A systematic review protocol vol.98, pp.37, 2015, https://doi.org/10.1097/md.0000000000017112